Ocular Electrical Stimulation Feedback for Vision Therapy Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for eye diseases such as age-related macular degeneration and genetic retinal disorders lack effective systems for preventing, arresting, or reversing disease progression, and often have side effects from pharmaceutical interventions.
Innovation Solution
Systems and methods involving electrical stimulation of the eye, combined with pharmaceuticals and stem cell therapies, are used to modulate ocular processes, with monitoring and feedback mechanisms to ensure efficacy and safety, including impedance monitoring and visual interrogation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If electrical stimulation is used to treat eye diseases, then cell survival and integration are improved, but safety monitoring and side effect management become more complex
Solution Approach 1:
The patent implements impedance monitoring as a feedback mechanism to track tissue response during electrical stimulation. The system measures impedance changes to verify therapy delivery and assess tissue health, enabling real-time adjustment of stimulation parameters to optimize cell survival while maintaining safety.
Solution Approach 2:
The patent replaces complex mechanical monitoring systems with electrical impedance measurement. By using electrical signals to assess tissue properties, the system achieves non-invasive monitoring of cell integration and tissue response, simplifying the overall system architecture while maintaining comprehensive monitoring capabilities.
2Reliability
If pharmaceutical interventions are used to treat eye diseases, then disease progression is addressed, but side effects increase
Solution Approach 1:
The patent substitutes pharmaceutical interventions with electrical stimulation therapy. By using controlled electrical currents to modulate ocular processes, the system achieves therapeutic effects without the harmful side effects associated with pharmaceutical drugs, while maintaining efficacy in treating eye diseases.
Solution Approach 2:
The patent changes the fundamental parameter of treatment delivery from chemical (pharmaceutical) to physical (electrical). By adjusting electrical parameters such as amplitude, frequency, and pulse width, the system achieves diverse therapeutic effects without the systemic side effects of pharmaceutical interventions.
3Manufacturing precision
If therapy delivery is optimized for efficacy, then treatment precision is improved, but measurement and monitoring requirements increase
Solution Approach 1:
The patent uses impedance monitoring as a feedback mechanism to verify therapy delivery in real-time. By continuously measuring impedance changes, the system confirms that electrical stimulation is reaching the target tissue with the intended precision, enabling therapeutic optimization without excessive measurement complexity.
Solution Approach 2:
The patent employs the tissue's own electrical properties (impedance) as the measurement signal. The tissue itself provides the measurement data through its natural electrical characteristics, eliminating the need for separate complex measurement systems and simplifying therapy verification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances therapeutic benefits by improving cell survival and integration, reducing side effects, and optimizing treatment delivery, while providing real-time feedback for personalized therapy.
Implementation Method 1
Systems and methods involving electrical stimulation of the eye, combined with pharmaceuticals and stem cell therapies, are used to modulate ocular processes
Implementation Method 2
monitoring and feedback mechanisms to ensure efficacy and safety, including impedance monitoring
Data Source
AI summary
Illustrative methods and devices for providing stimulus to the eye to treat vision disorders. Systems and methods for feedback relating to the stimulus itself as well as the effect of such stimulus on the patient are provided. Various examples may include therapies for vision disorders that can progress to blindness, such as macular degeneration or other diseases and disease processes.


